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Background: We report the fundus autofluorescence (FAF), spectral-domain optical coherence tomographic
(SD-OCT), microperimetric, and multifocal electroretinographic (mfERG) findings before, during, and after successful
treatment of a primary intraocular lymphoma (PIOL).
Findings: A 57-year-old man had biopsy-proven PIOL in his left eye, and he was treated with intravitreal methotrexate
injections for 8 months. Before treatment, fundus examination disclosed many small, yellow lesions with distinct
boundaries in the posterior fundus which became atrophic 9 months after the initial treatment. FAF showed a pattern
of granular hypoautofluorescence and hyperautofluorescence before the treatments and patchy hypoautofluorescence
corresponding to retinal pigment epithelial (RPE) atrophy after the treatments. SD-OCT showed increased nodularity at
the level of and above the RPE, a separation of Bruch membrane from the RPE, partial damage of the RPE, disruption of
the photoreceptor inner segment/outer segment (IS/OS) junction, multiple hyperreflective signals in the inner retina,
foveal thinning, and parafoveal thickening. After treatment, the hyperreflective infiltrations in the inner retina were
markedly decreased, and the RPE and IS/OS junction were restored. The foveal thinning and parafoveal thickening
resolved, and the central choroidal thickness decreased. During the follow-up, the mfERGs remained decreased. In
contrast, microperimetry showed a partial improvement of the retinal sensitivity.
Conclusion: FAF and SD-OCT are useful noninvasive methods to evaluate the retinal and choroidal changes before
and after treatment of PIOL. Our results suggest that visual recovery after successful treatment may be limited once
macula is infiltrated.
Keywords: Electroretinograms; Fundus autofluorescence; Humphrey visual field test; Microperimetry; Multifocal
electroretinograms; Primary intraocular lymphoma; Spectral-domain optical coherence tomographyFindings
Introduction
A primary intraocular lymphoma (PIOL) is a type of pri-
mary central nervous system lymphoma (PCNSL). Patients
with a PIOL often have iritis, vitreous opacities, and retinal
infiltrations and are often misdiagnosed as having uveitis.
Fundus autofluorescence (FAF) imaging has been recently
used to diagnose various retinal diseases such as retinitis* Correspondence: egawa.m@tokushima-u.ac.jp
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in any medium, provided the original work is ppigmentosa [1,2]. The autofluorescence pattern in the FAF
images depends on the distribution of lipofuscin in the ret-
inal pigment epithelial (RPE) cells. An increase in the
hyperautofluorescence indicates an increase in the lipofus-
cin in the RPE due to the degeneration of the photorecep-
tor outer segments [3].
Several studies have reported on the FAF findings such
as the granular pattern in the eyes with a PIOL [4,5]. We
have also reported on the FAF images in two cases of
PIOL before treatment [6]. To the best of our knowledge,
there is only one report describing changes of the FAF
findings in a case of PIOL after successful treatment [4].n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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changes of the FAF images, spectral-domain optical coher-
ence tomographic (SD-OCT) images, retinal sensitivities
determined by microperimetry, and multifocal electroreti-
nograms (mfERGs) after a successful treatment of an eye
with a PIOL. An approval was obtained from the Institu-
tional Review Board of Tokushima University Hospital to
perform this study. This study is in compliance with the
Helsinki Declaration. Also, the patient has given consent
for the report to be published.
Case report
A 57-year-old man presented with decreased vision in the
left eye of 1-month duration. At the initial examination,
the best-corrected visual acuity (BCVA) was 20/25. Oph-
thalmoscopy showed retinal infiltrations in the posterior
pole and diffuse vitreous opacities. Diagnostic vitrectomy
was performed, and the cytodiagnosis revealed class V
atypical lymphocytes. The interleukin (IL)-10 level was
3,150 pg/ml, IL-6 level was 102 pg/ml, and the IL-10/IL-6
ratio of the vitreous was 30.9 which led to a diagnosis of
PIOL. Because a PCNSL was not detected by magnetic
resonance imaging, the patient was treated with intravit-
real injections of methotrexate (MTX). After weekly intra-
vitreal MTX injections (400 μg/0.1 ml) for 1 month, the
level of IL-10 in the aqueous humor became undetectable,
and then monthly maintenance injections were performed
for seven more months.
We evaluated the FAF and SD-OCT images, visual
fields, microperimetric, mfERG, and full-field ERG find-
ings before and 1, 6, and 9 months after the initial MTX
injection. The BCVA was 20/20 before treatment and
improved to 20/16 after 9 months (Table 1). Before
treatment, fundus examination showed many small,
yellowish lesions with distinct boundaries resembling
drusen in the posterior fundus (Figure 1A, left). AfterTable 1 Chronological change of ophthalmologic findings in
Before treatment
BCVA 20/20
Mean deviation on HFA (dB) −13.95
Mean retinal sensitivity on microperimetry (dB) 0.3
Full-field ERG Subnormal
Amplitudes of mfERG Markedly decreased
Total macular volume (6.0-mm circle, mm3) 10.2
Foveal retinal thickness (μm) 155
Subfoveal choroidal thickness (μm) 245
Length of IS/OS junction (μm) Not detectable
BCVA, best-corrected visual acuity; ERG, electroretinogram; IS/OS, inner segment/ou
electroretinogram; N/A not available.treatment, the yellowish lesions gradually changed to at-
rophy of the RPE (Figure 1B,C,D, left).
FAF was performed with the Topcon TRC-50DX ret-
inal camera (Topcon, Tokyo, Japan) with an excitation
bandpass filter of 535 to 585 nm and a barrier bandpass
filter of 615 to 715 nm. FAF showed a slight hypoauto-
fluorescence and hyperautofluorescence granular pat-
tern before treatment (Figure 1A, right), and these
lesions changed to patchy hypoautofluorescence corre-
sponding RPE atrophy after the treatments (Figure 1B,
C,D, right).
SD-OCT was performed with the Heidelberg Spectralis
(Heidelberg Engineering, Heidelberg, Germany). The fo-
veal thickness, subfoveal choroidal thickness, and length
of photoreceptor inner segment/outer segment (IS/OS)
junction were manually measured using the caliper func-
tion. A retinal thickness map of the central 6.0-mm circle
was made automatically by the built-in software. The SD-
OCT images showed increased nodularity at the level of
and above the RPE, a separation of Bruch membrane from
the RPE, and a partial destruction of the RPE. There was
also a disruption of the IS/OS junction, multiple hyperre-
flective signals in the inner retina, and foveal thinning
(Figure 2A, left; Table 1).
After treatment, the degree of hyperreflective infiltra-
tion in the inner retina markedly decreased. The RPE
and IS/OS junction were restored, and the foveal thick-
ness recovered (Figure 2B,C,D, left; Table 1). Enhanced
depth imaging OCT (EDI-OCT) showed that the subfo-
veal choroidal thickness gradually decreased during the
treatment (Figure 2A,B,C,D, middle; Table 1).
Before treatment, the total macular volume in the central
6.0-mm circle was increased although the foveal thickness
was reduced (Figure 2A, right; Table 1). After treatment,
the total macular volume was reduced (Figures 2B,C,D,
right; Table 1).the left eye with PIOL after treatment
After treatment














Figure 1 Fundus and fundus autofluorescence (FAF) findings
in the eye with primary intraocular lymphoma (PIOL).
(A) Before treatment. Fundus photograph (left) shows small
yellowish lesions resembling drusen in the posterior fundus, and FAF
(right) shows a granular pattern of slight hypoautofluorescence and
hyperautofluorescent rings (arrows). (B) One month after the initial
methotrexate injection. (C) Six months after the initial injection.
(D) Nine months after the initial injection. The yellowish lesions
gradually change to retinal pigment epithelial (RPE) atrophy in the
fundus photographs, and the patchy hypoautofluorescence
corresponding to the RPE atrophy is seen in the FAF images
9 months after the initial injection.
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Humphrey Field Analyzer (HFA, Carl Zeiss Meditec,
Dublin, CA, USA), and the 30-2 program with the
SITA was used. The mean deviation (MD) increased
from −13.95 dB before treatment (Figure 3A) to −7.23 dB
after treatment (Figure 3B).
The mean retinal sensitivity within the central 10° was
measured with a fundus-related microperimeter (MP1,
Nidek, Gamagori, Japan). The follow-up examinations
were performed on the earlier tested retinal points. The
Goldmann III stimuli and a 4-2 staircase strategy were
used, and a rectangular 3° × 3° test grid with 24 stimulus
locations covering an area of 10° was applied. The meanretinal sensitivity increased from 0.3 dB before treat-
ment (Figure 3C) to 4.1 dB after treatment (Figure 3D).
Full-field ERGs (LE-4000, Tomey, Nagoya, Japan)
and mfERGs (LE-4100, Tomey, Nagoya, Japan) were
recorded according to the International Society for
Electrophysiology of Vision (ISCEV) standards [7,8].
The amplitudes of the mfERGs were markedly de-
creased in the left eye before treatment (Figure 3E).
During the follow-up period, the amplitudes of the
mfERG remained markedly reduced (Figure 3F). The
amplitudes of the scotopic, photopic, and 30-Hz flicker
ERGs were reduced after the treatments (Figure 3G,H).
Color vision with the Farnsworth D15 test showed
tritan-like responses after the treatment.
Discussion
Earlier, we found that the FAF images of the two eyes
with PIOL had a granular pattern that consisted of
hypoautofluorescent spots surrounded by hyperauto-
fluorescent rings [6]. In addition, SD-OCT showed
nodular hyperreflective areas not only under but also
above the RPE. Because FAF depends on the distribu-
tion of lipofuscin in the RPE cells, it was suspected that
the areas of lymphomatous infiltration into the sub-RPE
space can alter the RPE metabolism leading to the
hyperautofluorescence. Ishida et al. suggested that the
hypoautofluorescence in PIOL patients is caused by
RPE atrophy or the blockage of autofluorescence from
the RPE by the tumor cells [5]. Casady et al. showed
that the hyperautofluorescent spots on FAF changed to
hypoautofluorescent spots corresponding to the atro-
phic areas in the RPE after treatment [4]. Similarly, we
found that the FAF images had a granular pattern of
slight hypoautofluorescence and hyperautofluorescence
before treatment and patchy hypoautofluorescence cor-
responding to RPE atrophy after the treatments. These
differences in the FAF findings may be useful for deter-
mining the sites of PIOL activity.
Fardeau et al. examined 244 patients with chronic
uveitis who underwent vitreous sampling for cyto-
logical analysis [9]. They reported that the fovea in the
OCT images was significantly thinner in the eyes with
PIOL than in those with severe posterior uveitis. Also,
our case had a reduction of foveal thickness before
treatment.
Information about the visual fields in the eyes with
PIOL is limited. Kim et al. reported that the visual fields
were constricted in a case of PIOL and slightly recov-
ered after treatment [10]. In our case, the visual field
determined by HFA and microperimetry improved after
treatment but not to the normal level. Yasuda et al. re-
ported that the pre-treatment full-field ERGs were the
negative type in the eyes with a PIOL suggesting that




Figure 2 Spectral-domain optical coherence tomography and enhanced depth imaging-OCT findings in the eye with PIOL. The left
column shows the SD-OCT images; the middle column, the EDI-OCT images; and the right column, the retinal thickness map. (A) Before treatment with
methotrexate, (B) 1 month after initial methotrexate injection, (C) 6 months after initial injection, and (D) 9 months after initial injection. SD-OCT shows
increased nodularity at the level of and above the retinal pigment epithelium (RPE) (yellow arrowheads), a separation of Bruch membrane from the
RPE (arrows), damage of the RPE, disruption of the photoreceptor inner and outer segment (IS/OS) junction and external limiting membrane (ELM),
multiple hyperreflective signals in the inner retina (white arrowheads), and foveal thinning (A, left). After initial injection of methotrexate, the
hyperreflective infiltrations in the retina are markedly decreased, the RPE, the IS/OS junction, and ELM are restored, and the foveal thickness recovers
(B to D, left). The subfoveal choroidal thickness gradually decreases in the EDI-OCT images (A to D, middle). A thickening of the retina is observed
outside the central sector before treatment (A, right), but the retinal thickness gradually decreases outside the central sector after treatment (B to D, right).
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fully recover after chemotherapy [11]. In our case,
the markedly decreased amplitudes of mfERGs and
full-field ERGs also did not improve after treatment.
Even though the RPE and IS/OS lines are restored and
the foveal thickness on SD-OCT images are recovered,
the global retinal damage due to the tumor infiltration
into the retina may have persisted after successful
treatment.
This study has limitations. We studied only one case
of PIOL, and further studies examining a larger numberof cases treated for PIOL will be needed to accurately
determine the chronological changes of the ophthalmo-
logic findings before and after treatment.
In conclusion, FAF and SD-OCT may be useful, non-
invasive methods to evaluate the retina and choroid be-
fore and after treatment for PIOL. Regardless of the
good visual acuity and improvement of retinal sensitiv-
ity, the amplitudes of the mfERGs remained markedly
decreased. For better prognosis of retinal function,
prompt treatment before lymphoma invasion of macu-
lar area may be necessary.
Figure 3 Humphrey visual fields, microperimetry, multifocal electroretinogram (mfERGs), and full-field ERG findings with PIOL. The left
column shows images before methotrexate, and the right column shows images 9 months after treatment. (A, B) Humphrey visual field test,
(C, D) microperimetry, (E, F) mfERG, and (G, H) full-field ERG. Mean deviation of 30-2 program in Humphrey Field Analyzer increases from −13.95 dB
before treatment to −7.23 dB after treatment. Mean retinal sensitivity within the central 10° in microperimetry increases from 0.3 dB before treatment
to 4.1 dB. Amplitudes of mfERGs are markedly decreased without improvement. ERGs are subnormal and do not improve after treatment. In addition,
the rod ERG, photopic ERG, and 30-Hz flicker ERG are reduced.
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